KRAS and adenoma: Their findings showed that β‐catenin gene mutations were present in varying amounts across dysplastic aberrant crypt foci (ACF), adenomas, and adenocarcinomas, with some cases of K‐ras mutations also detected in hyperplastic ACF and adenocarcinomas.